account_balance
Investment manager · 13F filer · SEC CIK 1969764
Propel Bio Management, LLC
Reported value$191Mas of Jun 30, 2026
Positions29 4 new, 13 sold out
Top 10 weight68.1%PAGP alone is 16%
FiledAug 1344 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
PAGPPlains Gp Holdings Lp-cl
16.2%
ACHVAchieve Life Sciences Inc
13.8%Added +7%
CORTCorcept Therapeutics Inc
6.2%Trimmed −8%
PHATPhathom Pharmaceuticals I
6.0%Added +25%
DCTHDelcath Systems Inc
5.7%Trimmed −11%
MISTMilestone Pharmaceuticals
5.2%Added +80%
CMPSCompass Pathways PLC
4.2%Trimmed −23%
KYTXKyverna Therapeutics Inc
4.1%Added +37%
ARTVArtiva Biotherapeutics In
3.5%Added +376%
ABEOAbeona Therapeutics Inc
3.2%Trimmed −26%
AQSTAquestive Therapeutics In
3.1%Added +103%
PALIPalisade Bio Inc
2.8%Added +132%
PAGPPlains Gp Holdings Lp-cl
16.2%
ACHVAchieve Life Sciences Inc
13.8%Added +7%
CORT6.2%PHAT6.0%DCTHDelcath Systems Inc
5.7%Trimmed −11%
MIST5.2%CMPS4.2%KYTX4.1%ARTV3.5%ABEO3.2%AQST3.1%PALI2.8%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
PAGP Plains Gp Holdings Lp-cl 16.2% HeldACHV Achieve Life Sciences Inc 13.8% Added +7%CORT Corcept Therapeutics Inc 6.2% Trimmed −8%PHAT Phathom Pharmaceuticals I 6.0% Added +25%DCTH Delcath Systems Inc 5.7% Trimmed −11%MIST Milestone Pharmaceuticals 5.2% Added +80%CMPS Compass Pathways PLC 4.2% Trimmed −23%KYTX Kyverna Therapeutics Inc 4.1% Added +37%ARTV Artiva Biotherapeutics In 3.5% Added +376%ABEO Abeona Therapeutics Inc 3.2% Trimmed −26%AQST Aquestive Therapeutics In 3.1% Added +103%PALI Palisade Bio Inc 2.8% Added +132%
What changed